We are live on ! Find out more

1,043 hedge funds and large institutions have $35.1B invested in Biogen in 2021 Q3 according to their latest regulatory filings, with 73 funds opening new positions, 352 increasing their positions, 397 reducing their positions, and 124 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.51% less ownership

Funds ownership: 83.71% → 83.2% (-0.51%)

6% less funds holding

Funds holding: 1,107 → 1,043 (-64)

11% less repeat investments, than reductions

Existing positions increased: 352 | Existing positions reduced: 397

14% less capital inflows, than outflows

Capital inflows: $2.44B | Capital outflows: $2.83B

28% less call options, than puts

Call options by funds: $1.26B | Put options by funds: $1.76B

41% less first-time investments, than exits

New positions opened: 73 | Existing positions closed: 124

44% less funds holding in top 10

Funds holding in top 10: 27 → 15 (-12)

Holders
1,043
Holders Change
-64
Holders Change %
-5.78%
% of All Funds
18.19%
Holding in Top 10
15
Holding in Top 10 Change
-12
Holding in Top 10 Change %
-44.44%
% of All Funds
0.26%
New
73
Increased
352
Reduced
397
Closed
124
Calls
$1.26B
Puts
$1.76B
Net Calls
-$496M
Net Calls Change
-$365M

BIIB Hedge Fund Activity: Q3 2021 in Review

1,043 of the 5,733 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q3 2021, worth a combined $35.1B — down 20% from $43.6B a quarter earlier.

Sellers outnumbered buyers: 124 funds closed out of BIIB and 73 opened new positions — a net loss of 51 holders — while 397 trimmed existing stakes and 352 added.

The largest buyer was BlackRock, adding an estimated $226M. The largest seller was Marshall Wace, cutting an estimated $210M.

  • 1,043 institutional investors held Biogen (BIIB) as of Q3 2021, down from 1,107 in Q2 2021.
  • Funds reported $35.1B of Biogen stock for Q3 2021, down 20% quarter-over-quarter.
  • 73 funds opened new Biogen positions in Q3 2021 and 124 closed out, a net change of -51 holders.
  • The largest Biogen buyer in Q3 2021 was BlackRock, an estimated $226M added.
  • The largest Biogen seller in Q3 2021 was Marshall Wace, an estimated $210M sold.

Based on aggregated 13F filings for Q3 2021.